Related Experiment Video
Updated: Jul 16, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
LncRNA SNHG1: role in tumorigenesis of multiple human cancers
Huang Zeng1, Shouang Zhou1, Weiqiang Cai1
1School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
Abstract:
Small nucleolar RNA host gene 1 (SNHG1) is an important member of the SNHG family. This family is composed of a group of host genes that can be processed into small nucleolar RNAs and play important biological functions. In an oncogenic role, the SNHG1 expression is increased in various cancers, which has immense application prospects in the diagnosis, treatment, and prognosis of malignant tumors. In this review, we have summarized the role and molecular mechanism of SNHG1 in the development of various cancers. In addition, we have emphasized the clinical significance of SNHG1 in cancers in our article. This molecule is expected to be a new marker for potential usage in the diagnosis, prognosis, and treatment of cancer.
Insights
Small nucleolar RNA host gene 1 (SNHG1) is upregulated in many cancers, playing a key role in tumor development. This review highlights SNHG1
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Small nucleolar RNA host gene 1 (SNHG1) is a critical member of the SNHG family, involved in processing small nucleolar RNAs.
- Aberrant SNHG1 expression is observed in various human cancers, suggesting its involvement in oncogenesis.
Purpose of the Study:
- To review the oncogenic roles and molecular mechanisms of SNHG1 in cancer development.
- To emphasize the clinical significance of SNHG1 in the context of malignant tumors.
Main Methods:
- Literature review of studies investigating SNHG1 in various cancer types.
- Analysis of molecular mechanisms underlying SNHG1's function in cancer progression.
- Compilation of data on the clinical relevance of SNHG1 in cancer diagnosis, prognosis, and treatment.
Main Results:
- SNHG1 expression is significantly increased in a wide range of cancers.
- SNHG1 contributes to cancer development through diverse molecular pathways.
- Clinical studies indicate SNHG1's potential as a diagnostic and prognostic biomarker.
Conclusions:
- SNHG1 plays a crucial oncogenic role in multiple cancers.
- SNHG1 holds promise as a potential biomarker for cancer diagnosis, prognosis, and therapeutic strategies.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Nucleolus
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
MicroRNAs

